Noritaka Ishii
Papers
2
Total Citations
10
H-Index
2
About
Dr. Noritaka Ishii is a leading urologic oncologist whose research focuses on optimizing surgical and perioperative strategies for high-risk prostate and bladder cancers. His work critically evaluates the trade-offs between aggressive surgical intervention and neoadjuvant therapies, providing evidence to guide clinical decision-making. A landmark 2023 study, cited 5 times, compared neoadjuvant chemohormonal therapy against extended pelvic lymph-node dissection in over 450 high-risk prostate cancer patients undergoing robot-assisted radical prostatectomy, offering vital insights into postoperative complications and oncologic control. More recently, in a 2025 multicenter retrospective analysis of 429 patients, Dr. Ishii examined the impact of robot-assisted versus open radical cystectomy on peritoneal carcinomatosis and survival in muscle-invasive bladder cancer. By leveraging large, real-world datasets, his contributions directly address unresolved questions in minimally invasive surgery, helping to refine treatment protocols and improve patient outcomes. Dr. Ishii’s work is essential reading for clinicians and researchers navigating the evolving landscape of robotic oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2